Hongwei Cheng
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 3
-
- RNA modifications and cancer 2
- Histone Deacetylase Inhibitors Research 2
- RNA Interference and Gene Delivery 2
-
- Sarcoma Diagnosis and Treatment 5
-
- Nanoparticle-Based Drug Delivery 2
-
- Nanoplatforms for cancer theranostics 2
-
- Musculoskeletal synovial abnormalities and treatments 2
Hongwei Cheng
14 papers receiving 895 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 256
- Molecular Biology 563
- Pulmonary and Respiratory Medicine 208
- Biomaterials 82
- Oncology 125
Countries citing papers authored by Hongwei Cheng
This map shows the geographic impact of Hongwei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Cheng more than expected).
Fields of papers citing papers by Hongwei Cheng
This network shows the impact of papers produced by Hongwei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Cheng. The network helps show where Hongwei Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongwei Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2017 | 19 | |
| 4 | 2017 | 35 | |
| 5 | 2017 | 184 | |
| 6 | 2016 | 26 | |
| 7 | 2016 | 95 | |
| 8 | 2015 | 73 | |
| 9 | 2015 | 209 | |
| 10 | 2014 | 26 | |
| 11 | 2013 | 71 | |
| 12 | 2010 | 50 | |
| 13 | 2010 | 27 | |
| 14 | 2009 | 39 | |
| 15 | 2008 | 49 |
About Hongwei Cheng
Hongwei Cheng is a scholar working on Pulmonary and Respiratory Medicine, Molecular Medicine and Cancer Research, having authored 15 papers that have together received 906 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (5 papers), Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Nanoplatforms for cancer theranostics (2 papers), Histone Deacetylase Inhibitors Research (2 papers), RNA Interference and Gene Delivery (2 papers) and Musculoskeletal synovial abnormalities and treatments (2 papers). The work is most often cited by research in Cancer Research (256 citations), Molecular Biology (563 citations) and Pulmonary and Respiratory Medicine (208 citations). Hongwei Cheng has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Yuzhuo Wang, Torsten O. Nielsen, Jinjun Shi, Diana Askhatova, Yanlan Liu, Xiaoyuan Ji, Tingyuan Yang, Poul H. Sorensen, Amal M. El-Naggar and Martin Gleave. Their work appears in journals such as Angewandte Chemie International Edition, The Journal of Cell Biology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.